Fibromyalgia Management – FDA Approves Cymbalta Drug

by General Manager on 23rd June 2008

in All ME/ Chronic Fatigue Syndrome And Fibromyalgia News

FDA Approves Cymbalta(R) for the Management of Fibromyalgia
Cymbalta is the first serotonin-norepinephrine reuptake inhibitor with proven efficacy for reducing pain in patients with fibromyalgia. ..


Leave a Comment

Previous post:

Next post: